Laying the foundations for personalized medicines.
Marshall
A
A
D017326:Clinical Trials, Phase III as Topic; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics*; D019992:Databases as Topic; D064420:Drug-Related Side Effects and Adverse Reactions; D015971:Gene Expression Regulation, Enzymologic / Q000235:genetics*; D006801:Humans; D007527:Isoenzymes / Q000235:genetics*; D008967:Molecular Biology / Q000639:trends*; D009154:Mutation / Q000235:genetics; D010375:Pedigree; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D010597:Pharmacogenetics / Q000639:trends*; D010599:Pharmacokinetics; D010641:Phenotype; D011110:Polymorphism, Genetic / Q000235:genetics; D044465:White People
D007527:Isoenzymes; D004364:Pharmaceutical Preparations; D003577:Cytochrome P-450 Enzyme System